Today's Low
₹ 1,235.00
Today's High
₹ 1,259.00
52 Weeks Low
₹ 1,601.00
52 Weeks High
₹ 2,650.00
Lower
₹ 995.80
Upper
₹ 1,493.60
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Total Current Assets | 313.6 | 435.6 | 194.6 | 132.7 | 114.4 | 80.2 |
Total Non-Current Assets | 430.4 | 213.7 | 130.6 | 116.2 | 73.1 | 67.0 |
Total Assets | 743.9 | 649.4 | 325.2 | 248.9 | 187.5 | 147.2 |
Total Current Liabilities | 236.1 | 171.2 | 128.4 | 87.7 | 72.7 | 62.7 |
Total Non-Current Liabilities | -7.0 | 5.1 | 30.8 | 43.6 | 35.2 | 22.3 |
Shareholder's Funds | 514.8 | 473.1 | 166.0 | 117.7 | 79.7 | 62.2 |
Total Liabilities | 743.9 | 649.4 | 325.2 | 248.9 | 187.5 | 147.2 |
The Industry Debt to Equity Ratio stands at 0.86, vs the Debt to Equity Ratio of 0.77, which results in a Positive aspect.
The Industry Quick Ratio stands at 1.33, vs the Quick Ratio of 0.79, which results in a Negative aspect.
The Industry Current Ratio stands at 1.94, vs the Current Ratio of 1.51, which results in a Negative aspect.
The Industry Price to BV stands at 10.52, vs the Price to BV of 3.90, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Total Income | 423.6 | 433.7 | 300.4 | 263.2 | 206.3 | 135.5 |
Total Expenditure | 362.8 | 325.1 | 233.7 | 208.0 | 172.2 | 114.0 |
Operating Profit(Excl OI) | 66.5 | 117.5 | 71.9 | 56.7 | 34.6 | 26.3 |
Add: Other Income | 5.7 | 9.0 | 5.2 | 1.4 | 0.5 | 4.8 |
Operating Profit | 66.5 | 117.5 | 71.9 | 56.7 | 34.6 | 26.3 |
Less: Interest | 8.6 | 5.2 | 4.5 | 4.3 | 4.0 | 3.2 |
PBDT | 57.9 | 112.3 | 67.4 | 52.4 | 30.7 | 23.1 |
Less: Depreciation Amortization | 9.6 | 8.2 | 6.7 | 4.8 | 4.0 | 3.6 |
PBT & Exceptional Items | 48.4 | 104.1 | 60.7 | 47.6 | 26.6 | 19.5 |
Less: Exceptional Income Expenses | -3.6 | 0.0 | 0.0 | 0.0 | 0.8 | 0.0 |
Profit Before Tax | 44.8 | 104.1 | 60.7 | 47.6 | 27.4 | 19.5 |
Less: Taxation | -0.7 | 8.3 | 8.4 | 9.8 | 6.9 | 6.5 |
Profit After Tax | 45.5 | 95.9 | 52.3 | 37.8 | 20.5 | 13.0 |
Earnings Per Share | 2.1 | 4.3 | 2.6 | 1.9 | 1.0 | 0.0 |
The Industry PE Ratio stands at 58.70, vs the PE Ratio of 75.55, which results in a Positive aspect.
The Industry PAT Margin stands at 13.09, vs the PAT Margin of 14.36, which results in a Positive aspect.
The Industry Dividend Yield stands at 0.43, vs the Dividend Yield of 0.16, which results in a Negative aspect.
The Industry PAT Growth stands at 40.87, vs the PAT Growth of 83.95, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Profit Before Tax | 44.8 | 104.1 | 60.7 | 47.6 | 27.4 | 0.0 |
Tax Paid | -9.3 | -18.4 | -9.8 | -8.2 | -6.0 | 0.0 |
Adjustment | 20.7 | 11.6 | 6.8 | 8.6 | 7.6 | 0.0 |
Changes In Working Capital | 44.8 | 104.1 | 60.7 | 47.6 | 27.4 | 0.0 |
Cash Flow after changes in Working Capital | 37.1 | 38.6 | 29.5 | 33.5 | 13.3 | 0.0 |
Cash Flow from Operating Activities | 27.8 | 20.2 | 19.7 | 25.3 | 7.4 | 0.0 |
Cash Flow from Investing Activities | -101.1 | -196.7 | -20.7 | -40.2 | -16.8 | 0.0 |
Cash Flow from Financing Activities | 37.8 | 235.0 | -4.7 | 10.0 | 17.4 | 0.0 |
Net Cash Inflow / Outflow | -35.6 | 58.6 | -5.7 | -4.9 | 8.0 | 0.0 |
Opening Cash & Cash Equivalents | 63.0 | 4.5 | 10.2 | 15.7 | 7.8 | 0.0 |
Closing Cash & Cash Equivalent | 27.4 | 63.0 | 4.5 | 10.8 | 15.7 | 0.0 |
The Industry PFCF Ratio stands at 8.64, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
The Industry PCF RATIO stands at 47.24, vs the PCF RATIO of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 842.1 | 966.7 | 1,143.6 | 1,245.1 | 1,206.1 | 900.9 | 884.0 | 985.3 | 1,046.7 | 1,236.2 | 1,068.3 |
Total Income | 854.2 | 974.3 | 1,153.8 | 1,253.6 | 1,221.3 | 916.4 | 902.3 | 988.9 | 1,093.9 | 1,264.2 | 1,098.0 |
Total Expenditure | 732.1 | 764.2 | 930.2 | 1,082.4 | 1,026.9 | 789.1 | 731.9 | 765.8 | 808.6 | 877.2 | 810.0 |
PBIDT (Excl OI) | 109.9 | 202.5 | 213.4 | 162.7 | 179.1 | 111.8 | 152.2 | 219.5 | 238.1 | 358.9 | 258.3 |
Other Income | 12.1 | 7.6 | 10.2 | 8.5 | 15.2 | 15.5 | 18.3 | 3.5 | 47.2 | 28.0 | 29.7 |
Operating Profit | 122.0 | 210.0 | 223.6 | 171.2 | 194.3 | 127.3 | 170.5 | 223.1 | 285.3 | 387.0 | 288.0 |
Interest | 3.8 | 30.1 | 29.3 | 32.0 | 28.3 | 13.6 | 10.2 | 11.8 | 9.9 | 12.2 | 26.4 |
Exceptional Items | 0.0 | 0.0 | 0.0 | -35.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 118.3 | 179.9 | 194.3 | 103.3 | 166.1 | 113.7 | 160.3 | 211.2 | 275.4 | 374.7 | 261.6 |
Depreciation | 65.8 | 67.8 | 60.1 | 25.3 | 23.8 | 23.1 | 23.3 | 21.5 | 20.8 | 20.6 | 19.0 |
Profit Before Tax | 52.4 | 112.1 | 134.2 | 78.0 | 142.2 | 90.6 | 137.0 | 189.8 | 254.7 | 354.2 | 242.6 |
Tax | 17.9 | 34.3 | 39.2 | -91.5 | 26.0 | 19.5 | 39.0 | 14.7 | 26.6 | 30.1 | 11.2 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 34.6 | 77.8 | 95.0 | 169.5 | 116.2 | 71.1 | 98.0 | 175.1 | 228.1 | 324.1 | 231.5 |
Net Profit | 34.6 | 77.8 | 95.0 | 169.5 | 116.2 | 71.1 | 98.0 | 175.1 | 228.1 | 324.1 | 231.5 |
ADDITIONAL INFOS: | |||||||||||
Equity Capital | 233.9 | 233.9 | 221.7 | 221.7 | 221.7 | 221.7 | 221.7 | 221.7 | 221.7 | 221.7 | 200.9 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 1.5 | 3.4 | 4.3 | 7.7 | 5.2 | 3.2 | 4.4 | 7.9 | 10.3 | 15.0 | 11.5 |
Operating Profit Margin | 14.5 | 21.7 | 19.5 | 13.7 | 16.1 | 14.1 | 19.3 | 22.6 | 27.3 | 31.3 | 27.0 |
Net Profit Margin | 4.1 | 8.0 | 8.3 | 13.6 | 9.6 | 7.9 | 11.1 | 17.8 | 21.8 | 26.2 | 21.7 |
The Industry Net Sales Growth stands at 22.94, vs the Net Sales Growth of 27.60, which results in a Positive aspect.
The Industry Mcap Growth stands at 41.85, vs the Mcap Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 1,297.80 | 1,329.06 | 1,255.82 |
R3 | 1,284.87 | 1,283.33 | 1,247.86 |
R2 | 1,271.93 | 1,271.16 | 1,245.21 |
R1 | 1,255.92 | 1,254.38 | 1,242.55 |
Pivot | 1,242.98 | 1,242.21 | 1,242.98 |
S1 | 1,226.97 | 1,225.43 | 1,237.25 |
S2 | 1,214.03 | 1,213.26 | 1,234.59 |
S3 | 1,198.02 | 1,196.48 | 1,231.94 |
S4 | 1,182.00 | 1,155.36 | 1,223.98 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
65.24
Neutral
RSI
52.16
Neutral
ROC
2.24
Bullish
UltimateOscillator
44.31
Neutral
Williams Indicator
-36.67
Neutral
CCI Indicator
47.92
Neutral
MACD
-2,006.58
Bearish
Stochastic Indicator
63.94
Neutral
ATR
43.64
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
08-09-2023 | 2.00 | 20 | Final |
08-09-2022 | 2.00 | 20 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
03-05-2024 | Final Dividend & Audited Results |
20-01-2024 | Quarterly Results |
02-11-2023 | Quarterly Results |
04-08-2023 | Quarterly Results |
11-07-2023 | Preferential Issue of shares |
05-05-2023 | Final Dividend & Audited Results |
24-01-2023 | Quarterly Results |
04-11-2022 | Quarterly Results |
25-07-2022 | Quarterly Results |
25-04-2022 | Final Dividend & Audited Results |
17-01-2022 | Quarterly Results |
23-10-2021 | Quarterly Results |
14-08-2021 | Quarterly Results |